documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
11 rows where docket_id = "FDA-2024-P-3293" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-P-3293-0011 | FDA | None FDA-2024-P-3293 | Final Response Letter from FDA CDER to Newcastle Bioscience LLC | Other | Approval | 2024-12-27T05:00:00Z | 2024 | 12 | 2024-12-27T05:00:00Z | 2024-12-27T20:32:43Z | 0 | 0 | 090000648688ca84 | ||
| FDA-2024-P-3293-0009 | FDA | None FDA-2024-P-3293 | Suitability Petition Amendment from Newcastle Bioscience LLC | Other | Amendment | 2024-08-01T04:00:00Z | 2024 | 8 | 2024-08-01T04:00:00Z | 2024-08-01T20:31:12Z | 0 | 0 | 09000064866136a4 | ||
| FDA-2024-P-3293-0010 | FDA | None FDA-2024-P-3293 | Attachment 1 - Petition Letter Updated | Supporting & Related Material | Background Material | 2024-08-01T04:00:00Z | 2024 | 8 | 2024-08-01T20:31:36Z | 0 | 0 | 09000064866136aa | |||
| FDA-2024-P-3293-0008 | FDA | None FDA-2024-P-3293 | Completeness Assessment Correspondence | Other | Assessment Document or Analysis | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T04:00:00Z | 2024-08-29T17:07:04Z | 0 | 0 | 090000648660e301 | ||
| FDA-2024-P-3293-0005 | FDA | None FDA-2024-P-3293 | Lacosamide 2024 A3 | Supporting & Related Material | Background Material | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T12:34:39Z | 0 | 0 | 09000064865ec7b9 | |||
| FDA-2024-P-3293-0006 | FDA | None FDA-2024-P-3293 | Lacosamide 2024 A4 | Supporting & Related Material | Background Material | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T12:34:52Z | 0 | 0 | 09000064865ec7bc | |||
| FDA-2024-P-3293-0003 | FDA | None FDA-2024-P-3293 | Lacosamide 2024 A1 | Supporting & Related Material | Background Material | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T12:34:08Z | 0 | 0 | 09000064865ec7b7 | |||
| FDA-2024-P-3293-0002 | FDA | None FDA-2024-P-3293 | Acknowledgment Letter from FDA DMS to Newcastle Bioscience LLC | Other | Acknowledgement Letter/Receipt | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T04:00:00Z | 2024-07-15T12:33:52Z | 0 | 0 | 09000064865ec799 | ||
| FDA-2024-P-3293-0004 | FDA | None FDA-2024-P-3293 | Lacosamide 2024 A2 | Supporting & Related Material | Background Material | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T12:34:21Z | 0 | 0 | 09000064865ec7b8 | |||
| FDA-2024-P-3293-0007 | FDA | None FDA-2024-P-3293 | Lacosamide 2024 A5 | Supporting & Related Material | Background Material | 2024-07-15T04:00:00Z | 2024 | 7 | 2024-07-15T12:35:10Z | 0 | 0 | 09000064865ec8a8 | |||
| FDA-2024-P-3293-0001 | FDA | None FDA-2024-P-3293 | Suitability Petition from Newcastle Bioscience LLC | Other | Petition(s) | 2024-07-12T04:00:00Z | 2024 | 7 | 2024-07-12T04:00:00Z | 2024-12-26T18:45:26Z | 0 | 0 | 09000064865ec379 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;